BEAM
Price
$28.14
Change
+$0.37 (+1.33%)
Updated
Dec 24 closing price
Capitalization
2.86B
68 days until earnings call
Intraday BUY SELL Signals
ZNTL
Price
$1.38
Change
+$0.03 (+2.22%)
Updated
Dec 24 closing price
Capitalization
99.71M
69 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs ZNTL

Header iconBEAM vs ZNTL Comparison
Open Charts BEAM vs ZNTLBanner chart's image
Beam Therapeutics
Price$28.14
Change+$0.37 (+1.33%)
Volume$430.29K
Capitalization2.86B
Zentalis Pharmaceuticals
Price$1.38
Change+$0.03 (+2.22%)
Volume$304.24K
Capitalization99.71M
BEAM vs ZNTL Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. ZNTL commentary
Dec 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and ZNTL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 25, 2025
Stock price -- (BEAM: $28.14 vs. ZNTL: $1.38)
Brand notoriety: BEAM and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 20% vs. ZNTL: 43%
Market capitalization -- BEAM: $2.86B vs. ZNTL: $99.71M
BEAM [@Biotechnology] is valued at $2.86B. ZNTL’s [@Biotechnology] market capitalization is $99.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than ZNTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while ZNTL’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 5 bearish.
  • ZNTL’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ZNTL.

Price Growth

BEAM (@Biotechnology) experienced а +9.92% price change this week, while ZNTL (@Biotechnology) price change was +2.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

ZNTL is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.86B) has a higher market cap than ZNTL($99.7M). BEAM YTD gains are higher at: 13.468 vs. ZNTL (-54.455). ZNTL has higher annual earnings (EBITDA): -152.83M vs. BEAM (-434.55M). BEAM has more cash in the bank: 1.08B vs. ZNTL (281M). ZNTL has less debt than BEAM: ZNTL (36.7M) vs BEAM (151M). BEAM has higher revenues than ZNTL: BEAM (55.7M) vs ZNTL (26.9M).
BEAMZNTLBEAM / ZNTL
Capitalization2.86B99.7M2,865%
EBITDA-434.55M-152.83M284%
Gain YTD13.468-54.455-25%
P/E RatioN/AN/A-
Revenue55.7M26.9M207%
Total Cash1.08B281M383%
Total Debt151M36.7M411%
FUNDAMENTALS RATINGS
BEAM: Fundamental Ratings
BEAM
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMZNTL
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 15 days ago
82%
Declines
ODDS (%)
Bearish Trend 9 days ago
85%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIZN7.920.09
+1.15%
Citizens Holding Co.
FRRPF4.48N/A
N/A
Fiera Cap Corp
HOKCF0.94N/A
N/A
Hong Kong & China Gas Co., Ltd.
JTEKF8.42N/A
N/A
JTEKT Corp.
CYCL0.04N/A
N/A
Cycclone Inc.

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+1.33%
CRSP - BEAM
72%
Closely correlated
+0.44%
RXRX - BEAM
61%
Loosely correlated
+0.92%
NTLA - BEAM
61%
Loosely correlated
+1.80%
PRME - BEAM
60%
Loosely correlated
-3.25%
AXON - BEAM
57%
Loosely correlated
+0.02%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with NGNE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
+2.22%
NGNE - ZNTL
49%
Loosely correlated
-0.05%
SYRE - ZNTL
47%
Loosely correlated
-0.54%
MGNX - ZNTL
45%
Loosely correlated
+1.25%
BEAM - ZNTL
43%
Loosely correlated
+1.33%
FATE - ZNTL
43%
Loosely correlated
+3.40%
More